Lawyer Monthly Magazine - February 2019 Edition

FEB 2019 77 Transactions www. lawyer-monthly .com This announcement appears as a matter of record only Anagenesis Biotechnologies Completes Fundraising Legal advisers to Anagenesis Biotechnologies: Anagenesis Biotechnologies Completes Fundraising Anagenesis Biotechnologies (“Anagenesis”), a private biotechnology company producing stem-cell derived lineages to develop drugs treating muscle and metabolic diseases, announces a €3 million investment by the Boehringer Ingelheim Venture Fund (“BIVF”) and current shareholder Cap Innov’Est (“CIE”), a French interregional-based seed fund. The funds raised will support the preclinical work required to develop new, proprietary small compounds identified through the company’s phenotypic screen towards a lead clinical candidate for Duchenne Muscular Dystrophy (DMD). This will drive the company to complete this fund raising to at least a €15 million round A investment in the next 18 months. This round A will be led by BIVF and co-invested by CIE and two new investors. This announcement appears as a matter of record only Agrifood Abruzzo Acquired by D’Arta Legal adviser to Agrifood Abruzzo: Agrifood Abruzzo Acquired by D'Arta D'Arta NV - Belgium based company leader in the field of frozen products (vegetables, fruit and derivatives) -purchased the entire stake in Agrifood Abruzzo, a company headquartered in Montichiari (BS), one of the leading Italian players in the agri-food sector. The legal assistance to the seller was provided by the Law Firm Amato Matera & Associati of Brescia through the lawyer partners Giuseppe Amato and Ambra De Domenico . Thanks to this acquisition D'Arta N.Vv increases its production of quality agricultural products, also strengthening its position in the Italian and European market. "The excellent relationships and mutual trust have led us to a shared vision on the future of our societies," spoke Karel Talpe, Director of D'Arta. The people currently working in Agrifood and D'Arta are at the centre of the future growth strategy."